HBW
MDT icon

Hazlett, Burt & Watson’s Medtronic MDT Stock Holding History

Hazlett, Burt & Watson’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$75K Sell
874
-28
-3% -$2.68K 0.02% 380
2025
Q4 		$87K Buy
902
+31
+4% +$3.01K 0.03% 363
2025
Q3 		$82K Buy
871
+1
+0.1% +$92 0.03% 344
2025
Q2 		$76K Buy
870
+794
+1,045% +$67.3K 0.03% 320
2025
Q1 		$7K Hold
76
– – ﹤0.01% 622
2024
Q4 		$6K Hold
76
– – ﹤0.01% 603
2024
Q3 		$7K Sell
76
-435
-85% -$36.6K ﹤0.01% 562
2024
Q2 		$40K Sell
511
-199
-28% -$16.3K 0.02% 362
2024
Q1 		$61K Sell
710
-31
-4% -$2.65K 0.04% 305
2023
Q4 		$61K Sell
741
-200
-21% -$15.2K 0.04% 282
2023
Q3 		$74K Buy
941
+51
+6% +$4.27K 0.06% 254
2023
Q2 		$80K Buy
890
+55
+7% +$4.74K 0.06% 239
2023
Q1 		$67K Buy
835
+313
+60% +$25.5K 0.05% 246
2022
Q4 		$41K Sell
522
-1,578
-75% -$128K 0.04% 298
2022
Q3 		$169K Buy
2,100
+8
+0.4% +$719 0.16% 128
2022
Q2 		$188K Buy
2,092
+59
+3% +$5.98K 0.17% 122
2022
Q1 		$225K Buy
+2,033
New +$215K 0.18% 116

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hazlett, Burt & Watson's MDT Position: Q1 2026 in Review

Hazlett, Burt & Watson reduced its Medtronic (MDT) stake by 3.1% in Q1 2026, selling an estimated $2.68K and leaving 874 shares worth $75K. The position accounts for 0.02% of the portfolio, ranked #380.

Hazlett, Burt & Watson first reported a position in MDT in Q1 2022 and has held it in 17 quarters since. The position peaked at $225K in Q1 2022. 2,230 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Hazlett, Burt & Watson held 874 shares of Medtronic worth $75K as of Q1 2026.
  • Hazlett, Burt & Watson sold 28 Medtronic shares in Q1 2026, an estimated $2.68K.
  • Medtronic made up 0.02% of Hazlett, Burt & Watson's portfolio in Q1 2026, its #380 holding.
  • Hazlett, Burt & Watson first reported a position in Medtronic in Q1 2022 and has held it in 17 quarters since.
  • Hazlett, Burt & Watson's Medtronic position peaked at $225K in Q1 2022.
  • 2,230 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q1 2026, filed 14 May 2026.